Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6882
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial ; volume:16 ; number:1 ; day:24 ; month:10 ; year:2016 ; pages:1-6 ; date:12.2016
BMC complementary and alternative medicine ; 16, Heft 1 (24.10.2016), 1-6, 12.2016
- Urheber
-
Bao, Chunhui
- Beteiligte Personen und Organisationen
-
Zhang, Jingzhi
Liu, Jinmei
Liu, Huirong
Wu, Luyi
Shi, Yin
Li, Jing
Hu, Zhihai
Dong, Yongzheng
Wang, Siyao
Zeng, Xiaoqing
Wu, Huangan
SpringerLink (Online service)
- DOI
-
10.1186/s12906-016-1386-4
- URN
-
urn:nbn:de:1111-201611217627
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bao, Chunhui
- Zhang, Jingzhi
- Liu, Jinmei
- Liu, Huirong
- Wu, Luyi
- Shi, Yin
- Li, Jing
- Hu, Zhihai
- Dong, Yongzheng
- Wang, Siyao
- Zeng, Xiaoqing
- Wu, Huangan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial
Effects of moxibustion on miRNA-133b, Pitx3/TH, and neurotransmitters in the midbrain of rats with diarrhea-predominant irritable bowel syndrome
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction
Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial
Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study
The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial
Effects of moxibustion on miRNA-133b, Pitx3/TH, and neurotransmitters in the midbrain of rats with diarrhea-predominant irritable bowel syndrome
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction
Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial
Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study
The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome
Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial
Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
Effect of acupuncture for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized clinical trial
Effects of moxibustion on miRNA-133b, Pitx3/TH, and neurotransmitters in the midbrain of rats with diarrhea-predominant irritable bowel syndrome
Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome
Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction
Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial
Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: a functional magnetic resonance imaging study
The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome